[Federal Register Volume 62, Number 247 (Wednesday, December 24, 1997)]
[Notices]
[Page 67377]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-33666]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Vaccine Advisory Committee (NVAC), Subcommittee on 
Future Vaccines, Subcommittee on Immunization Coverage, and 
Subcommittee on Vaccine Safety: Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meetings.

    Name: National Vaccine Advisory Committee (NVAC).
    Times and Dates: 9 a.m.-2 p.m., January 12, 1998. 8:30 a.m.-1:15 
p.m., January 13, 1998.
    Place: Hubert H. Humphrey Building, Room 800, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Notice: In the interest of security, the Department has 
instituted stringent procedures for entrance to the Hubert H. 
Humphrey Building by non-government employees. Thus, persons without 
a government identification card should plan to arrive at the 
building each day either between 8 and 8:30 a.m. or 12:30 and 1 p.m. 
so they can be escorted to the meeting. Entrance to the meeting at 
other times during the day cannot be assured.
    Purpose: This committee advises and makes recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program responsibilities.
    Matters To Be Discussed: Agenda items will include updates on 
the National Vaccine Program Office (NVPO) activities; the National 
Vaccine Plan and NVAC's role in defining priorities for action; 
unmet needs funding--past, present and future; adult immunization: 
report of the workgroup; use of non-traditional sites for adult 
immunization; influenza: a growing need for pandemic preparedness; 
and a discussion on vaccines for international travel.
    In addition, there will be updates on welfare reform and effects 
on immunization; moving towards a Department of Health and Human 
Services' vaccine safety action plan; work group on philosophical 
exemptions--final report; the presidential initiative on 
immunization registries; global use of critically needed vaccines--
strategies to consider. There will be reports from the Subcommittee 
on Immunization Coverage, Subcommittee on Future Vaccines, and 
Subcommittee on Vaccine Safety.

    Name: Subcommittee on Immunization Coverage.
    Time and Date: 2 p.m.-5 p.m., January 12, 1998.
    Place: Hubert H. Humphrey Building, Room 423A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee will identify and propose solutions 
that provide a multifaceted and holistic approach to reducing 
barriers that result in low immunization coverage for children.
    Matters To Be Discussed: This subcommittee will hold a 
discussion on the review of recommendations from the document, 
``Strategies to Sustain Immunization Coverage,'' and the 
finalization of those recommendations.

    Name: Subcommittee on Future Vaccines.
    Time and Date: 2 p.m.-5 p.m., January 12, 1998.
    Place: Hubert H. Humphrey Building, Room 405A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: The Subcommittee on Future Vaccines will develop policy 
options and guide national activities which will lead to accelerated 
development, licensure, and best use of new vaccines in the simplest 
possible immunization schedules.
    Matters To Be Discussed: This subcommittee will hold discussions 
regarding the continued evaluation of methods to remove barriers to 
development, licensure and use of safe and effective new vaccines; 
combination vaccines, strategic options; and defining future 
vaccines policy issues for travelers' vaccines.

    Name: Subcommittee on Vaccine Safety.
    Time and Date: 2 p.m.-5 p.m., January 12, 1998.
    Place: Hubert H. Humphrey Building, Room 800, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee will review issues relevant to 
vaccine safety and adverse reactions to vaccines.
    Matters To Be Discussed: This subcommittee will hold discussions 
regarding its goals; a report from the Task Force on Safer Childhood 
Vaccines; a project report on benefit-risk communication curriculum 
development; and agenda items for the next meeting.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Felecia D. Pearson, 
Committee Management Specialist, NVPO, CDC, 1600 Clifton Road, NE, 
M/S D50, Atlanta, Georgia 30333, telephone 404/639-4450.

    Dated: December 19, 1997.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 97-33666 Filed 12-23-97; 8:45 am]
BILLING CODE 4163-18-P